Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1M Buy
4,446
+2,193
+97% +$532K 0.03% 259
2022
Q2
$548K Buy
+2,253
New +$552K 0.02% 340
2021
Q1
Sell
-1,150
Closed -$264K 300
2020
Q4
$264K Sell
1,150
-2,847
-71% -$656K 0.02% 214
2020
Q3
$1.02M Buy
+3,997
New +$990K 0.09% 127

Other funds holding AMGN

55I LLC's AMGN Position: Q3 2022 in Review

55I LLC increased its Amgen (AMGN) stake by 97% in Q3 2022, buying an estimated $532K and bringing the position to 4,446 shares worth $1M. The position accounts for 0.03% of the portfolio, ranked #259.

55I LLC first reported a position in AMGN in Q3 2020 and has held it in 4 quarters since. The position peaked at $1.02M in Q3 2020. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • 55I LLC held 4,446 shares of Amgen worth $1M as of Q3 2022.
  • 55I LLC bought 2,193 Amgen shares in Q3 2022, an estimated $532K.
  • Amgen made up 0.03% of 55I LLC's portfolio in Q3 2022, its #259 holding.
  • 55I LLC first reported a position in Amgen in Q3 2020 and has held it in 4 quarters since.
  • 55I LLC's Amgen position peaked at $1.02M in Q3 2020.
  • 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.